An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
Launched by MARGARET LIOTTA · Mar 13, 2019
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of vaginal dilator designed to help women who have had endometrial or cervical cancer and are receiving radiation therapy. Radiation can sometimes cause the vagina to narrow, a condition known as vaginal stenosis, which can be uncomfortable and make it difficult for women to engage in certain activities. In this trial, researchers are comparing a new dilator with a silicone band to the standard dilator currently used. They hope the new design will be easier for women to use and more effective at preventing vaginal narrowing.
To be eligible for this trial, participants must be women aged between 65 and 74 who have been diagnosed with endometrial or cervical cancer and are undergoing radiation therapy. They should also be able to speak English. Participants will receive either the new or the standard dilator and will be asked to use it as directed. This study is currently recruiting participants, and it aims to help improve the quality of life for women undergoing treatment for these types of cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of endometrial or cervical cancer
- • Undergoing external beam radiation therapy with or without brachytherapy
- • English-speaking
- Exclusion Criteria:
- • History or current presence of fistula
About Margaret Liotta
Margaret Liotta is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, she leads a team that collaborates closely with healthcare professionals, regulatory bodies, and research institutions. Under her guidance, the organization emphasizes ethical standards, rigorous methodologies, and patient safety in all clinical trials. Margaret Liotta's leadership fosters a culture of transparency and excellence, ensuring that each study contributes valuable insights to the scientific community and enhances the development of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maywood, Illinois, United States
Patients applied
Trial Officials
Margaret R Liotta, DO
Principal Investigator
Loyola University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials